Role of angiotensin II receptor subtypes in conjunctival wound healing

Shiro Mizoue1, Masaru Iwai, Ayumi Ide

  • 1Department of Ophthalmology, Division of Medical Biochemistry and Cardiovascular Biology, Ehime University School of Medicine, Ehime, Japan.

Current Eye Research
|February 28, 2006
PubMed
Abstract

Insights

Angiotensin II (Ang II) receptor subtypes play opposing roles in subconjunctival wound healing. AT1a receptor deficiency inhibited healing, while AT2 receptor deficiency enhanced it, suggesting an antagonistic interaction.

Area of Science:

  • Ophthalmology
  • Wound Healing Research
  • Molecular Biology

Background:

  • Subconjunctival injury triggers a complex wound-healing response.
  • Angiotensin II (Ang II) signaling pathways are implicated in tissue repair.
  • The specific roles of Ang II receptor subtypes (AT1a and AT2) in ocular wound healing remain unclear.

Purpose of the Study:

  • To elucidate the distinct roles of AT1a and AT2 receptors in subconjunctival wound healing.
  • To investigate the impact of receptor deficiency on key molecular and cellular aspects of healing.

Main Methods:

  • Subconjunctival blunt dissection model in wild-type, AT1a receptor-deficient (AT1aKO), and AT2 receptor-deficient (AT2KO) mice.
  • Histological assessment of collagen deposition and inflammatory cell infiltration.
  • Real-time PCR analysis of collagen, matrix metalloproteinase (MMP), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression.

Main Results:

  • Subconjunctival injury led to increased inflammation, collagen deposition, and altered MMP/TIMP-1 expression.
  • AT1aKO mice showed inhibited collagen deposition, cell infiltration, and TIMP-1 expression, with enhanced MMP2.
  • AT2KO mice exhibited exacerbated collagen deposition, cell infiltration, and TIMP-1 expression compared to wild-type.

Conclusions:

  • AT1a receptor stimulation appears to promote subconjunctival wound healing.
  • AT2 receptor stimulation seems to inhibit subconjunctival wound healing.
  • AT1a and AT2 receptor signaling act antagonistically in the subconjunctival wound healing process.